chlorpromazine has been researched along with Analgesic Overuse Headache in 1 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to describe a group of patients with chronic headache disorders (CH) and medication overuse headache (MOH) treated with intravenous chlorpromazine (IVC)." | 7.96 | Intravenous Chlorpromazine as Potentially Useful Treatment for Chronic Headache Disorders. ( Alessandro, L; Farez, MF; Goicochea, MT; Marrodan, M; Ruiz Yanzi, MA; Yorio, F, 2020) |
| "The aim of this study was to describe a group of patients with chronic headache disorders (CH) and medication overuse headache (MOH) treated with intravenous chlorpromazine (IVC)." | 3.96 | Intravenous Chlorpromazine as Potentially Useful Treatment for Chronic Headache Disorders. ( Alessandro, L; Farez, MF; Goicochea, MT; Marrodan, M; Ruiz Yanzi, MA; Yorio, F, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruiz Yanzi, MA | 1 |
| Goicochea, MT | 1 |
| Yorio, F | 1 |
| Alessandro, L | 1 |
| Farez, MF | 1 |
| Marrodan, M | 1 |
1 other study available for chlorpromazine and Analgesic Overuse Headache
| Article | Year |
|---|---|
Intravenous Chlorpromazine as Potentially Useful Treatment for Chronic Headache Disorders.
Topics: Administration, Intravenous; Adult; Aged; Chlorpromazine; Dopamine Antagonists; Drug Therapy, Combin | 2020 |